ArticleMolecules (Basel, Switzerland)2022

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis.

Francesca Clemente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.